Immunovant Inc

{ "date": [ "202703", "202803", "202903", "203003", "203103" ], "revenue_estimate": [ null, 49.39, 509.06, 1196.49, 1305.76 ], "ebit_estimate": [ -582.32, -628.94, -358.82, 155.74, 414.09 ], "ebitda_estimate": [ -636.05, -647.83, -142.14, null, null ], "net_income_estimate": [ -559.43, -611.29, -377.04, 163.92, 438.46 ], "per_share_eps_estimate": [ -2.66, -2.78, -1.66, 0.18, 1.75 ], "eps_nri_estimate": [ -2.62, -2.7, -1.57, -0.32, 1.79 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 4.29, 4.08, 3.78, null, null ], "pretax_income_estimate": [ -565.1, -617.07, -346.69, 164.61, 436.46 ], "operating_cash_flow_per_share_estimate": [ -2.01, -1.58, -0.5, null, null ], "roa_estimate": [ -68.8, -71.8, null, null, null ], "roe_estimate": [ -116.54, -106.76, -11.66, null, null ], "gross_margin_estimate": [ 90, 89.67, 89.67, 92, 91 ], "operating_cash_flow_estimate": [ -409.59, -321.44, -101.72, null, null ], "pettm_estimate": [ 0, 0, 0, 218.19, 22.69 ], "long_term_growth_rate_mean": 15.39, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 13.94, "future_eps_nri_estimate_growth": 15.39, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 32.61, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -3.47, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.25, "future_operating_cash_flow_per_share_estimate_growth": 37.66 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -134.76, -137.61, -144.18, -152.74, -137.74, -148.95, -141.92, -152.12 ], "ebitda_estimate": [ -150.64, -154.8, -159.01, -162.92, null, null, null, null ], "net_income_estimate": [ -130.16, -133.24, -140.83, -150.43, -138.37, -145.29, -150.13, -155.15 ], "per_share_eps_estimate": [ -0.61, -0.63, -0.65, -0.67, -0.63, -0.65, -0.61, -0.65 ], "eps_nri_estimate": [ -0.62, -0.63, -0.65, -0.68, -0.63, -0.65, -0.61, -0.65 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -130.16, -133.24, -140.83, -150.43, -138.37, -145.29, -150.13, -155.15 ], "operating_cash_flow_per_share_estimate": [ -0.51, -0.56, -0.48, -0.55, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -79.32, -94.35, -116.58, -151.3, null, null, null, null ], "gross_margin_estimate": [ null, null, null, 95, null, null, null, null ], "operating_cash_flow_estimate": [ -103.76, -113.93, -97.65, -111.89, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 15.39, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 13.94, "future_eps_nri_estimate_growth": 15.39, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 32.61, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -3.47, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.25, "future_operating_cash_flow_per_share_estimate_growth": 37.66 }